BPG is committed to discovery and dissemination of knowledge
Featured Articles
7/18/2016 10:51:00 AM | Browse: 819 | Download: 2100
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 24766
Country South Korea
ISSN 1948-5204 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Allergy
Manuscript Type Retrospective Study
Article Title Prognostic value of inflammation-based markers in patients with pancreatic cancer administered gemcitabine and erlotinib
Manuscript Source Invited Manuscript
All Author List Jae Min Lee, Hong Sik Lee, Jong Jin Hyun, Hyuk Soon Choi, Eun Sun Kim, Bora Keum, Yeon Seok Seo, Yoon Tae Jeen, Hoon Jai Chun, Soon Ho Um and Chang Duck Kim
Funding Agency and Grant Number
Funding Agency Grant Number
Korea Health Technology R and D Project through the Korea Health Industry Development Institute
Ministry of Health and Welfare, Republic of Korea HI14C3477
Corresponding Author Hong Sik Lee, MD, PhD, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University College of Medicine, Inchon-ro 73, Seongbuk-gu, Seoul 02841, South Korea. hslee60@korea.ac.kr
Key Words Pancreatic cancer; Neutrophil-to-lymphocyte ratio; C-reactive protein; Albumin; Prognostic factor
Core Tip This retrospective study validates the value of systemic inflammation-based markers as prognostic factors for pancreatic cancer (PC). The neutrophil-to-lymphocyte ratio and the C-reactive protein-to-albumin ratio, which can be determined from routine blood tests before chemotherapy, can be used as useful biomarkers in PC to predict a patient’s response to chemotherapy.
Publish Date 2016-07-08 09:44
Citation Lee JM, Lee HS, Hyun JJ, Choi HS, Kim ES, Keum B, Seo YS, Jeen YT, Chun HJ, Um SH, Kim CD. Prognostic value of inflammation-based markers in patients with pancreatic cancer administered gemcitabine and erlotinib. World J Gastrointest Oncol 2016; 8(7): 555-562
URL http://www.wjgnet.com/1948-5204/full/v8/i7/555.htm
DOI http://dx.doi.org/10.4251/wjgo.v8.i7.555
Full Article (PDF) WJGO-8-555.pdf
Full Article (Word) WJGO-8-555.doc